A double blind, randomized, placebo-controlled, single center, parallel group study to evaluate the effects of itopride (100 mg and 200 mg t.i.d.) on gastric motor and sensory functions in healthy volunteers
Phase of Trial: Phase II/III
Latest Information Update: 26 Jan 2010
At a glance
- Drugs Itopride (Primary)
- Indications Gastritis
- Focus Pharmacodynamics
- 03 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Oct 2006 New trial record.